Warsaw, Poland

Anna Puszko

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Warsaw. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Puszko. Retrieved from https://idiyas.com/inventor/anna-puszko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Puszko: Innovator in Cyclic Peptidomimetics

Introduction

Anna Puszko is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclic peptidomimetics. Her work focuses on innovative treatments for diseases associated with angiogenesis.

Latest Patents

Anna Puszko holds a patent for "Cyclic peptidomimetics, compositions containing them and their use in the treatment of diseases associated with angiogenesis." This invention relates to novel cyclic peptidomimetics and their pharmaceutical compositions. The applications of her invention are particularly relevant for treating tumors, chronic inflammation in psoriasis, diabetes, degenerative diseases of the eye (ARMD), nephropathy, and neuropathy.

Career Highlights

Anna Puszko is affiliated with the University of Warsaw, where she continues her research and development efforts. Her work has garnered attention for its potential impact on various medical conditions, showcasing her dedication to advancing healthcare solutions.

Collaborations

Some of her notable coworkers include Aleksandra Misicka-Kesik and Karolina Grabowska. Their collaborative efforts contribute to the innovative research environment at the University of Warsaw.

Conclusion

Anna Puszko's contributions to the field of cyclic peptidomimetics highlight her role as a leading inventor in pharmaceutical innovation. Her work promises to enhance treatment options for several serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…